Logo-ipp

Original

1. Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer
Mohamed M Darwish ORCID, Atef Y Riad, Dina A Salem, Ahmad E Essa, Marwa M Shakweer* ORCID, Diaa Eldin M. Sherif
Immunopathol Persa. 2022;8(1): e18. doi: 10.34172/ipp.2022.18
Scopus ID: 85119256857    
Article
PDF
XML
Cited By:
11
11

Original

2. Evaluating final pathology results in patients operated for intraductal papilloma
Reza Eshraghi Samani ORCID, Kian Dolatshahi ORCID, Kamran Dolatshahi ORCID, Masumeh Safaee* ORCID
Immunopathol Persa. 2025;11(1): e40645. doi: 10.34172/ipp.2025.40645
Scopus ID: 85215322023    
Article
PDF
XML
Cited By:
0
0
Original

3. Immunohistochemical analysis of clinicopathological predictors for BRCA1 protein alterations in invasive breast carcinoma; a cross-sectional study
Azar Naimi ORCID, Faezeh Saberi* ORCID, Elham Amjadi ORCID
Immunopathol Persa. 2026;12(1): e43787. doi: 10.34172/ipp.2025.43787
Scopus ID: 105026628886    
Article
PDF
XML
Cited By:
0
0
Original

4. Exploring RDW as a predictive marker for 5-year overall and progression-free survival in breast cancer; a retrospective, diagnostic cohort study
Ali Mir ORCID, Marzieh Lashkari ORCID, Ehsan Habibi* ORCID
Immunopathol Persa. 2026;12(2): e43883. doi: 10.34172/ipp.2025.43883
Article
PDF
XML
Cited By:
Meta-analysis

5. Systematic review and meta-analysis of hypofractionated and conventional fractionated radiotherapy on survival in breast cancer patients
Azadeh Haghiri ORCID, Jayran Zebardast ORCID, Atieh Akbari ORCID, Maryam Kalantari Khandani ORCID, Majid Shakiba ORCID, Naeimeh ShahrabiFarahani ORCID, Mohammad Esmaeil Akbari* ORCID, Mohammad Eslami ORCID
Immunopathol Persa. 2026;12(2): e44001. doi: 10.34172/ipp.2026.44001
Article
PDF
XML
Cited By: